๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

1298 CXCR3 AXIS IN PATIENTS WITH PRIMARY BILIARY CIRRHOSIS (PBC). A NOVEL MECHANISM OF ACTION OF URSODEOXYCHOLIC ACID (UDCA)

โœ Scribed by Manousou, P.; Koulentaki, M.; Voumvouraki, A.; Papadaki, H.; Notas, G.; Kolios, G.; Kouroumalis, E.


Book ID
123143958
Publisher
Elsevier Science
Year
2011
Tongue
English
Weight
56 KB
Volume
54
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Oral budesonide in the treatment of pati
โœ Paul Angulo; Roberta A. Jorgensen; Jill C. Keach; E. Rolland Dickson; Coleman Sm ๐Ÿ“‚ Article ๐Ÿ“… 2000 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 236 KB ๐Ÿ‘ 1 views

Ursodeoxycholic acid (UDCA) is a safe and effective medical therapy for most patients with primary biliary cirrhosis (PBC). However, some patients show an incomplete response to UDCA therapy. Treatment with corticosteroids may be of benefit although at the expense of systemic side effects. Budesonid